Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa
Main Authors: | Michel Ntiri, BS, Alessandra Haskin, MD, Eve J. Lowenstein, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512622004040 |
Similar Items
-
Prevalence of positive QuantiFERON gold in-tube testing in hidradenitis suppurativa
by: Tina Boortalary, et al.
Published: (2018-08-01) -
Serum infliximab levels and clinical response in hidradenitis suppurativa
by: Erwin Benassaia, et al.
Published: (2023-06-01) -
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa
by: Elisa Molinelli, et al.
Published: (2023-05-01) -
Refractory Hidradenitis Suppurativa: A Diagnosis to Consider
by: Rita Ornelas Saraiva, et al.
Published: (2023-01-01) -
Multimodal management of hidradenitis suppurativa
by: Gregor B.E. Jemec, MD, DMSc
Published: (2020-06-01)